Reply to Juan Gómez Rivas, Giorgio Gandaglia, and Francesco Montorsi’s Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36
Main Author: | Neal D. Shore |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168322023473 |
Similar Items
-
Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36
by: Juan Gómez Rivas, et al.
Published: (2022-12-01) -
El Simbolismo del grito en Jamás, nadie, de Beatriz Rivas
by: Maritza Manríquez Buendía
Published: (2018-11-01) -
SG-APSIC1128: BHQ instrument management at Bangkok Hospital
by: Rome Chomrak
Published: (2023-02-01) -
The fiction of Zora Neale Hurston: an assertion of black womanhood* The fiction of Zora Neale Hurston: an assertion of black womanhood*
by: Rita Terezinha Schmidt
Published: (2008-04-01) -
Examination of the effectiveness of Renzulli’s Enrichment Triad Program on Creativity of sharp-witted primary school level students
by: mozhgan shoushtari, et al.
Published: (2016-08-01)